Cargando…

Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey

Background & Methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates. Results & Conclusion: 94.4% of 3191 pwMS sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yun, Rodgers, William J, Middleton, Rodden M, Baheerathan, Aravindhan, Tuite-Dalton, Katherine A, Ford, David V, Nicholas, Richard, Group, MS Register Research
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313796/
https://www.ncbi.nlm.nih.gov/pubmed/34343866
http://dx.doi.org/10.1016/j.msard.2021.103175
_version_ 1783729416599240704
author Huang, Yun
Rodgers, William J
Middleton, Rodden M
Baheerathan, Aravindhan
Tuite-Dalton, Katherine A
Ford, David V
Nicholas, Richard
Group, MS Register Research
author_facet Huang, Yun
Rodgers, William J
Middleton, Rodden M
Baheerathan, Aravindhan
Tuite-Dalton, Katherine A
Ford, David V
Nicholas, Richard
Group, MS Register Research
author_sort Huang, Yun
collection PubMed
description Background & Methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates. Results & Conclusion: 94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in ‘Yes’ group and 27.0% in ‘No’ group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions.
format Online
Article
Text
id pubmed-8313796
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-83137962021-07-27 Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey Huang, Yun Rodgers, William J Middleton, Rodden M Baheerathan, Aravindhan Tuite-Dalton, Katherine A Ford, David V Nicholas, Richard Group, MS Register Research Mult Scler Relat Disord Article Background & Methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates. Results & Conclusion: 94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in ‘Yes’ group and 27.0% in ‘No’ group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions. Elsevier B.V. 2021-10 2021-07-27 /pmc/articles/PMC8313796/ /pubmed/34343866 http://dx.doi.org/10.1016/j.msard.2021.103175 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Huang, Yun
Rodgers, William J
Middleton, Rodden M
Baheerathan, Aravindhan
Tuite-Dalton, Katherine A
Ford, David V
Nicholas, Richard
Group, MS Register Research
Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey
title Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey
title_full Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey
title_fullStr Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey
title_full_unstemmed Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey
title_short Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey
title_sort willingness to receive a covid-19 vaccine in people with multiple sclerosis – uk ms register survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313796/
https://www.ncbi.nlm.nih.gov/pubmed/34343866
http://dx.doi.org/10.1016/j.msard.2021.103175
work_keys_str_mv AT huangyun willingnesstoreceiveacovid19vaccineinpeoplewithmultiplesclerosisukmsregistersurvey
AT rodgerswilliamj willingnesstoreceiveacovid19vaccineinpeoplewithmultiplesclerosisukmsregistersurvey
AT middletonroddenm willingnesstoreceiveacovid19vaccineinpeoplewithmultiplesclerosisukmsregistersurvey
AT baheerathanaravindhan willingnesstoreceiveacovid19vaccineinpeoplewithmultiplesclerosisukmsregistersurvey
AT tuitedaltonkatherinea willingnesstoreceiveacovid19vaccineinpeoplewithmultiplesclerosisukmsregistersurvey
AT forddavidv willingnesstoreceiveacovid19vaccineinpeoplewithmultiplesclerosisukmsregistersurvey
AT nicholasrichard willingnesstoreceiveacovid19vaccineinpeoplewithmultiplesclerosisukmsregistersurvey
AT groupmsregisterresearch willingnesstoreceiveacovid19vaccineinpeoplewithmultiplesclerosisukmsregistersurvey